Solid Biosciences (SLDB) Revenue (2022 - 2024)
Historic Revenue for Solid Biosciences (SLDB) over the last 3 years, with Q4 2024 value amounting to -$75000.0.
- Solid Biosciences' Revenue changed N/A to -$75000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was -$340000.0, marking a year-over-year decrease of 18099.17%. This contributed to the annual value of -$340000.0 for FY2024, which is N/A changed from last year.
- Per Solid Biosciences' latest filing, its Revenue stood at -$75000.0 for Q4 2024.
- Over the past 5 years, Solid Biosciences' Revenue peaked at $6.2 million during Q2 2022, and registered a low of -$121000.0 during Q1 2023.
- Its 3-year average for Revenue is $951333.3, with a median of -$85000.0 in 2024.
- Data for Solid Biosciences' Revenue shows a peak YoY increase of 2148.76% (in 2024) and a maximum YoY decrease of 2148.76% (in 2024) over the last 5 years.
- Quarter analysis of 3 years shows Solid Biosciences' Revenue stood at $6.2 million in 2022, then tumbled by 101.96% to -$121000.0 in 2023, then soared by 38.02% to -$75000.0 in 2024.
- Its Revenue was -$75000.0 in Q4 2024, compared to -$82000.0 in Q3 2024 and -$88000.0 in Q2 2024.